Matthew D. Plotkin, MD

Accepting new patients
Sees patients age 18 and up
Headshot of Matthew D. Plotkin, MD
Penn Medicine Provider

About me

  • Clinical Associate Professor of Medicine (Renal-Electrolyte and Hypertension)

My education and training

  • Medical School: State University of New York at Brooklyn
  • Residency: Mayo Clinic
  • Fellowship: Massachusetts General Hospital/Brigham and Women’s Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Plotkin is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Bauer MA, Todorova VK, Stone A, Carter W, Plotkin MD, Hsu PL, Wei JY, Su JL, Makhoul I. Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer , Cancers (Basel) , 31(24): 2021,6291


Plotkin M, O'Brien CA, Goellner J, Williams J, Carter W, Sharma S, Stone A. A Uromodulin Mutation Drives Autoimmunity and Kidney Mononuclear Phagocyte Endoplasmic Reticulum Stress , Am J Pathol, 190(12): 2020,2436-2452


Patil SS, Patil SM, Campbell R, Singh M, Plotkin M. Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient , Case Rep Med, 2020: 2020,6186471


Acklin S, Zhang M, Du W, Zhao X, Plotkin M, Chang J, Campisi J, Zhou D, Xia F. Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice , Sci Rep, 10(1): 2020,14170


Sharma S, Plotkin M. Id1 expression in kidney endothelial cells protects against diabetes-induced microvascular injury , FEBS Open Bio, 10(8): 2020,1447-1462


Matthew Plotkin and Angie Stone A Uromodulin mutation resulting in innate immune system activation , Poster Presentation, ASN Kidney Week, Washington DC: 2019


Plotkin M. Young blood for old kidneys? More questions than answers so far , Kidney Int, 94(2): 2018,235-236


Lee D, Shenoy S, Nigatu Y, Plotkin M Id proteins regulate capillary repair and perivascular cell proliferation following ischemia-reperfusion injury , Plos One, 9(2): 2014,e88417


Choi HY, Moon SJ, Ratliff BB, Ahn SH, Jung A, Lee M, Lee S, Lim BJ, Kim BS, Plotkin M, Ha SK, Park HC. Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury , Plos One, 9(2): 2014,e87853


Lee, D.H., Wolstein, J., Pudasaini, B., Plotkin, M INK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemia-reperfusion injury , Am J Physiol Renal Physiol, 302(1): 2012,F183-91